RVD-19029-04983
4 vaccinations
3 coded responses
42 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 852 / AZ
- Registered
- 2021-03-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-28
Registered in v-safe
-
2021-03-28
Dose 1 — Pfizer-BioNTech
- 2021-03-28
-
2021-03-29
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-04
- 2021-04-11
- 2021-04-18
-
2021-04-19
Dose 2 — Pfizer-BioNTech
- 2021-04-19
-
2021-04-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-04-21
Survey response — days 1–6 daily, dose 2MedDRA: Axillary pain — Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Muscle or body aches, Fatigue or tirednessFree text: Armpit painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-22
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · HeadacheAdult check-in
-
2021-04-23
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-05-03
- 2021-05-17
- 2021-05-24
- 2021-05-31
- 2021-07-19
- 2021-10-18
-
2021-11-22
Dose 3 — ModernaCo-administered: Flu
-
2021-11-23
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-11-25
- 2021-11-27
- 2021-11-29
- 2021-12-06
- 2021-12-13
- 2021-12-20
-
2021-12-27
Survey response — day 35, dose 3MedDRA: Nasopharyngitis — Feeling: Good · Be unable to do your normal daily activitiesFree text: Cold symptoms last weekMedDRA releases: 2024-11 · check-in free text available
- 2022-01-05
- 2022-02-21
- 2022-05-23
-
2022-10-16
Dose 4 — ModernaCo-administered: Flu
-
2022-10-17
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2022-10-18
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
- 2022-10-19
-
2022-10-20
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-11-20
-
2022-11-27
Survey response — day 42, dose 4MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Cold symptomsMedDRA releases: 2024-11 · check-in free text available
- 2023-01-15
- 2023-04-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-28 | Pfizer-BioNTech | |
| 2 | 2021-04-19 | Pfizer-BioNTech | |
| 3 | 2021-11-22 | Moderna | Flu |
| 4 | 2022-10-16 | Moderna | Flu |
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Armpit pain
Release 10 — day 35, dose 3
Symptoms: Cold symptoms last week
Release 12 — day 42, dose 4
Symptoms: Cold symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SRO | Axillary pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release